3,4-dihydroxyphenylethanol has been researched along with alpha-synuclein in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 6 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cooney, A; Goldstein, DS; Gross, D; Jinsmaa, Y; Sharabi, Y; Sullivan, P | 1 |
| Cerezo, AB; Garcia-Parrilla, MC; Hornedo-Ortega, R; Troncoso, AM | 1 |
| Cerezo, AB; Gallardo-Fernández, M; García-Parrilla, MC; Hornedo-Ortega, R; Troncoso, AM | 2 |
| Bucciantini, M; Cesaro, S; Leri, M; Palazzi, L; Polverino de Laureto, P; Stefani, M | 1 |
| Brunetti, G; Calabrese, V; Di Rosa, G; Leri, M; Saul, N; Schmitz-Linneweber, C; Scuto, M; Stefani, M | 1 |
| Acquasaliente, L; Bucciantini, M; Fongaro, B; Leri, M; Palazzi, L; Polverino de Laureto, P; Stefani, M | 1 |
| Cappelletto, E; Fongaro, B; Polverino de Laureto, P; Sosic, A; Spolaore, B | 1 |
| Goyal, B; Goyal, D; Kaur, G; Mankoo, OK | 1 |
9 other study(ies) available for 3,4-dihydroxyphenylethanol and alpha-synuclein
| Article | Year |
|---|---|
Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Synuclein; Animals; Antioxidants; Ascorbic Acid; Cations, Divalent; Chelating Agents; Copper; Dopamine; Edetic Acid; Humans; Iron; Manganese; PC12 Cells; Phenylethyl Alcohol; Protein Aggregates; Protein Multimerization; Rats | 2014 |
Protective effects of hydroxytyrosol against α-synuclein toxicity on PC12 cells and fibril formation.
Topics: alpha-Synuclein; Amyloid; Animals; PC12 Cells; Phenylethyl Alcohol; Rats; Spectrometry, Fluorescence | 2018 |
Melatonin, protocatechuic acid and hydroxytyrosol effects on vitagenes system against alpha-synuclein toxicity.
Topics: alpha-Synuclein; Animals; Heme Oxygenase (Decyclizing); HSP70 Heat-Shock Proteins; Hydroxybenzoates; Melatonin; Neuroprotective Agents; PC12 Cells; Phenylethyl Alcohol; Rats; Sirtuin 2 | 2019 |
Insight into the molecular mechanism underlying the inhibition of α-synuclein aggregation by hydroxytyrosol.
Topics: Acetates; alpha-Synuclein; Antioxidants; Antiparkinson Agents; Cell Line, Tumor; Cell Survival; Cyclopentane Monoterpenes; Humans; Levodopa; Molecular Structure; Parkinson Disease; Phenylethyl Alcohol; Protein Aggregation, Pathological; Protein Binding; Protein Conformation; Proteolysis; Pyrans | 2020 |
Healthspan Maintenance and Prevention of Parkinson's-like Phenotypes with Hydroxytyrosol and Oleuropein Aglycone in
Topics: Acetates; alpha-Synuclein; Animals; Animals, Genetically Modified; Caenorhabditis elegans; Cyclopentane Monoterpenes; Disease Models, Animal; Dopaminergic Neurons; Parkinson Disease; Phenylethyl Alcohol; Polyphenols; Pyrans; Treatment Outcome | 2020 |
Structural Features and Toxicity of α-Synuclein Oligomers Grown in the Presence of DOPAC.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Synuclein; Amyloid; Cell Proliferation; Dopamine; Dopaminergic Neurons; Humans; Oxidative Stress; Parkinson Disease; Phenylethyl Alcohol; Protein Aggregation, Pathological; Protein Multimerization | 2021 |
3,4-Dihydroxyphenylethanol and 3,4-dihydroxyphenylacetic acid affect the aggregation process of E46K variant of α-synuclein at different extent: Insights into the interplay between protein dynamics and catechol effect.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Synuclein; Catechols; Dopamine; Humans; Parkinson Disease; Phenylethyl Alcohol | 2022 |
Hydroxytyrosol and dopamine metabolites: Anti-aggregative effect and neuroprotective activity against α-synuclein-induced toxicity.
Topics: alpha-Synuclein; Dopamine; Humans; Neuroprotection; Parkinson Disease | 2023 |
Unveiling How Hydroxytyrosol Destabilizes α-Syn Oligomers Using Molecular Simulations.
Topics: alpha-Synuclein; Humans; Neurodegenerative Diseases; Parkinson Disease; Phenylethyl Alcohol | 2023 |